Overview

Efficacy Of Pregabalin In Subjects With Post-Stroke Central Neuropathic Pain

Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
Efficacy and Safety of flexibly dosed pregabalin compared to placebo among subjects with central post stroke pain (CPSP)
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Treatments:
Pregabalin